No role for glutathione S-transferase genotypes in Caucasian esophageal squamous cell or adenocarcinoma etiology: an European case-control study

被引:12
作者
Dura, Polat [1 ]
Salomon, Jody [1 ]
Te Morsche, Rene H. M. [1 ]
Roelofs, Hennie M. J. [1 ]
Kristinsson, Jon O. [1 ]
Wobbes, Theo [2 ]
Witteman, Ben J. M. [3 ]
Tan, Adriaan C. I. T. L. [4 ]
Drenth, Joost P. H. [1 ]
Peters, Wilbert H. M. [1 ]
机构
[1] Radboud Univ Nijmegen, Dept Gastroenterol, Med Ctr, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Dept Surg, Med Ctr, NL-6500 HB Nijmegen, Netherlands
[3] Hosp Gelderse Vallei, Dept Gastroenterol, NL-6717RP Ede, Netherlands
[4] Canisius Wilhelmina Hosp, Dept Gastroenterol, NL-6532 SZ Nijmegen, Netherlands
关键词
GENETIC POLYMORPHISMS; BARRETTS-ESOPHAGUS; METABOLIZING ENZYMES; CANCER-PATIENTS; PHASE-I; RISK; SUSCEPTIBILITY; GSTM1; GSTP1; CARCINOMA;
D O I
10.1186/1471-230X-13-97
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Identifying and monitoring high-risk patients can aid the prevention of esophageal cancer (EC). The interaction of environmental risk factor exposure and genetic susceptibility may contribute to the etiology of EC. Biotransformation enzymes such as Glutathione S-Transferases (GSTs) detoxify mutagenic and genotoxic compounds and therefore control the rate of detoxification of carcinogens. Functional polymorphisms in the genes coding for GSTs alter their enzyme activity in vitro, and were reported to modify EC risk in Asians. We hypothesized that altered enzyme activity GST genotypes influence the susceptibility for esophageal adeno- (EAC) and squamous cell carcinoma (ESCC) in Caucasians. Methods: We performed a case-control study including 440 Caucasian patients with EC and 592 healthy Caucasian controls matched for age and sex. Functional polymorphisms were selected and genotypes were determined in GST classes Alpha, Mu, Theta and Pi by means of polymerase chain reaction. Genotypes were classified into predicted high, intermediate and low enzyme activity categories based on in vitro activity data. The distribution of the activity genotypes were compared between patients with EAC or ESCC, and controls. Odds ratios (OR) with 95% confidence intervals (CI) were calculated by logistic regression analyses. Gene-gene interactions were tested and for comparison purposes, the predicted low and intermediate activity genotypes were combined. Genotypes with similar risks for EAC or ESCC were combined and analyzed for multiplicative effects. Results: Our analyses includes 327 patients with EAC and 106 patients with ESCC. Low or intermediate activity enzyme genotypes for GSTM1, GSTA1, GSTP1 I105V and A114V as well as for GSTT1, did not significantly modify the risk for ESCC or EAC in our Dutch population. Conclusion: Functional genotypes in GST genes are not involved in EAC or ESCC susceptibility in Caucasians, in contrast to results on ESCC from Asia or Africa.
引用
收藏
页数:7
相关论文
共 39 条
  • [1] Abbas A, 2004, WORLD J GASTROENTERO, V10, P3389
  • [2] BROCKMOLLER J, 1993, CANCER RES, V53, P1004
  • [3] Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis
    Bull, L. M.
    White, D. L.
    Bray, M.
    Nurgalieva, Z.
    El-Serag, H. B.
    [J]. DISEASES OF THE ESOPHAGUS, 2009, 22 (07) : 571 - 587
  • [4] Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma
    Casson, AG
    Zheng, Z
    Chiasson, D
    MacDonald, K
    Riddell, DC
    Guernsey, JR
    Guernsey, DL
    McLaughlin, J
    [J]. CANCER DETECTION AND PREVENTION, 2003, 27 (02): : 139 - 146
  • [5] Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma
    Casson, Alan G.
    Zheng, Zuoyu
    Porter, Geoffrey A.
    Guernsey, Duane L.
    [J]. CANCER DETECTION AND PREVENTION, 2006, 30 (05): : 423 - 431
  • [6] Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression
    Coles, BF
    Morel, F
    Rauch, C
    Huber, WW
    Yang, M
    Teitel, CH
    Green, B
    Lang, NP
    Kadlubar, FF
    [J]. PHARMACOGENETICS, 2001, 11 (08): : 663 - 669
  • [7] High enzyme activity UGT1A1 or low activity UGT1A8 and UGT2B4 genotypes increase esophageal cancer risk
    Dura, Polat
    Salomon, Jody
    Morsche, Rene H. M. Te
    Roelofs, Hennie M. J.
    Kristinsson, Jon O.
    Wobbes, Theo
    Witteman, Ben J. M.
    Tan, Adriaan C. I. T. L.
    Drenth, Joost P. H.
    Peters, Wilbert H. M.
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (06) : 1789 - 1796
  • [8] Glutathione S-transferase polymorphisms and their biological consequences
    Hayes, JD
    Strange, RC
    [J]. PHARMACOLOGY, 2000, 61 (03) : 154 - 166
  • [9] Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis
    Herszenyi, Laszlo
    Hritz, Istvan
    Pregun, Istvan
    Sipos, Ferenc
    Juhasz, Mark
    Molnar, Bela
    Tulassay, Zsolt
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (05) : 676 - 682
  • [10] Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity
    Hongo, Michio
    Nagasaki, Yutaka
    Shoji, Tomotaka
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (05) : 729 - 735